Literature DB >> 23441883

Diabetic ketoacidosis elicits systemic inflammation associated with cerebrovascular endothelial cell dysfunction.

Taylor E Close1, Gediminas Cepinskas, Tatsushi Omatsu, Keeley L Rose, Kelly Summers, Eric K Patterson, Douglas D Fraser.   

Abstract

OBJECTIVE: To determine if the DKA-induced inflammation in juvenile mice provokes activation and dysfunction of CVECs.
METHODS: DKA in juvenile mice was induced with administration of STZ and ALX. Blood from DKA mice was assessed for cytokines and soluble cell adhesion proteins, and either DKA plasma or exogenous compounds were applied to immortalized bEND3.
RESULTS: DKA increased circulating levels of IL-6, IL-8(KC), MCP-1, IL-10, sE-selectin, sICAM-1, and sVCAM-1. Stimulation of bEND3 with DKA plasma caused cellular activation (increased ROS and activation of NF-κΒ), upregulation of a proadhesive phenotype (E-selectin, ICAM-1, and VCAM-1), and increased leukocyte-bEND3 interaction (leukocyte rolling/adhesion). TEER, a measure of bEND3 monolayer integrity, was decreased by DKA plasma. Activation and dysfunction of bEND3 with DKA plasma were suppressed by plasma heat treatment (56°C, 1 hour) and replicated with the application of DKA recombinant cytomix (IL-6, IL-8[KC], MCP-1, and IL-10), implicating circulating inflammatory protein(s) as mediators. Treatment of bEND3 with β-OH-butyrate, the main ketone elevated in DKA, failed to mimic the DKA plasma-induced activation and dysfunction of bEND3.
CONCLUSIONS: DKA elicits systemic inflammation associated with CVEC activation and dysfunction, possibly contributing to DKA-associated intracranial microvascular complications.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  blood-brain barrier; cytokines; edema; endothelial cells; inflammation

Mesh:

Substances:

Year:  2013        PMID: 23441883     DOI: 10.1111/micc.12053

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  18 in total

1.  Cardiac arrest from acute myocardial infarction complicated with sodium-glucose cotransporter 2 inhibitor-associated ketoacidosis.

Authors:  Zhehao Dai; Yosuke Nishihata; Naoto Kawamatsu; Ikki Komatsu; Atsushi Mizuno; Masato Shimizu; Nozomi Toya; Shinichi Ishimatsu; Nobuyuki Komiyama
Journal:  J Cardiol Cases       Date:  2016-11-14

2.  Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis.

Authors:  William H Hoffman; Cornelia D Cudrici; Dallas Boodhoo; Alexandru Tatomir; Violeta Rus; Horea Rus
Journal:  Exp Mol Pathol       Date:  2019-04-13       Impact factor: 3.362

3.  Hyperketonemia (acetoacetate) upregulates NADPH oxidase 4 and elevates oxidative stress, ICAM-1, and monocyte adhesivity in endothelial cells.

Authors:  Preeti Kanikarla-Marie; Sushil K Jain
Journal:  Cell Physiol Biochem       Date:  2015-01-13

4.  Biomarkers and genetics of brain injury risk in diabetic ketoacidosis: A pilot study.

Authors:  Sholeen T Nett; Janelle A Noble; Daniel L Levin; Natalie Z Cvijanovich; Monica S Vavilala; J Dean Jarvis; Heidi R Flori
Journal:  J Pediatr Intensive Care       Date:  2014

5.  1,25(OH)2D3 inhibits oxidative stress and monocyte adhesion by mediating the upregulation of GCLC and GSH in endothelial cells treated with acetoacetate (ketosis).

Authors:  Preeti Kanikarla-Marie; Sushil K Jain
Journal:  J Steroid Biochem Mol Biol       Date:  2016-03-03       Impact factor: 4.292

Review 6.  Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes.

Authors:  Preeti Kanikarla-Marie; Sushil K Jain
Journal:  Free Radic Biol Med       Date:  2016-03-29       Impact factor: 7.376

7.  Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis.

Authors:  Nathan Kuppermann; Simona Ghetti; Jeff E Schunk; Michael J Stoner; Arleta Rewers; Julie K McManemy; Sage R Myers; Lise E Nigrovic; Aris Garro; Kathleen M Brown; Kimberly S Quayle; Jennifer L Trainor; Leah Tzimenatos; Jonathan E Bennett; Andrew D DePiero; Maria Y Kwok; Clinton S Perry; Cody S Olsen; T Charles Casper; J Michael Dean; Nicole S Glaser
Journal:  N Engl J Med       Date:  2018-06-14       Impact factor: 91.245

8.  Circulating matrix metalloproteinases in children with diabetic ketoacidosis.

Authors:  Aris Garro; Adam Chodobski; Joanna Szmydynger-Chodobska; Rongzi Shan; Shara R Bialo; Jonathan Bennett; Kimberly Quayle; Arleta Rewers; Jeffrey E Schunk; T Charles Casper; Nathan Kuppermann; Nicole Glaser
Journal:  Pediatr Diabetes       Date:  2016-02-04       Impact factor: 4.866

9.  Dynamic regulation of plasma matrix metalloproteinases in human diabetic ketoacidosis.

Authors:  Martin Woo; Eric K Patterson; Gediminas Cepinskas; Cheril Clarson; Tatsushi Omatsu; Douglas D Fraser
Journal:  Pediatr Res       Date:  2015-10-22       Impact factor: 3.756

10.  Diisopropylamine dichloroacetate, a novel pyruvate dehydrogenase kinase 4 inhibitor, as a potential therapeutic agent for metabolic disorders and multiorgan failure in severe influenza.

Authors:  Kazuhiko Yamane; Irene L Indalao; Junji Chida; Yoshikazu Yamamoto; Masaaki Hanawa; Hiroshi Kido
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.